Welcome to LookChem.com Sign In|Join Free
  • or
2-Bromo-4-hydroxynicotinonitrile is a chemical compound with the molecular formula C6H3BrN2O. It is an intermediate used in organic synthesis and is characterized by its brownish appearance and slight solubility in water. As a laboratory chemical, it is primarily utilized in scientific research and development activities.

635731-97-4

Post Buying Request

635731-97-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

635731-97-4 Usage

Uses

Used in Scientific Research and Development:
2-Bromo-4-hydroxynicotinonitrile is used as a chemical intermediate for [application reason] in the field of organic synthesis. It plays a crucial role in the synthesis of various organic compounds, contributing to the advancement of chemical research and the development of new materials and pharmaceuticals.
Used in Laboratory Settings:
2-Bromo-4-hydroxynicotinonitrile is used as a laboratory chemical for [application reason] in scientific research. It is essential for conducting experiments and testing hypotheses in the field of organic chemistry. Due to its potential to cause skin and eye irritation, it is crucial to handle and store 2-Bromo-4-hydroxynicotinonitrile correctly, using protective equipment and ensuring proper ventilation in the laboratory.

Check Digit Verification of cas no

The CAS Registry Mumber 635731-97-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,5,7,3 and 1 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 635731-97:
(8*6)+(7*3)+(6*5)+(5*7)+(4*3)+(3*1)+(2*9)+(1*7)=174
174 % 10 = 4
So 635731-97-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H3BrN2O/c7-6-4(3-8)5(10)1-2-9-6/h1-2H,(H,9,10)

635731-97-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-bromo-4-oxo-1H-pyridine-3-carbonitrile

1.2 Other means of identification

Product number -
Other names 2-bromo-4-hydroxy-nicotinonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:635731-97-4 SDS

635731-97-4Relevant academic research and scientific papers

ANTAGONISTS OF THE MGLU RECEPTOR AND USES THEREOF

-

Page/Page column 48, (2008/06/13)

The present invention discloses compounds of general formula (I) wherein X1-X4 and R1-R3 are as defined in the description. The present invention also discloses methods of treatment for pain, neurodegeneration and convulsive states in a host mammal in need thereof, and pharmaceutical compositions including those compounds.

Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists

Zheng, Guo Zhu,Bhatia, Pramila,Daanen, Jerome,Kolasa, Teodozyj,Patel, Meena,Latshaw, Steven,El Kouhen, Odile F.,Chang, Renjie,Uchic, Marie E.,Miller, Loan,Nakane, Masaki,Lehto, Sonya G.,Honore, Marie P.,Moreland, Robert B.,Brioni, Jorge D.,Stewart, Andrew O.

, p. 7374 - 7388 (2007/10/03)

SAR (structure-activity relationship) studies of triazafluorenone derivatives as potent mGluR1 antagonists are described. The triazafluorenone derivatives are non-amino acid derivatives and noncompetitive mGluR1 antagonists that bind at a putative alloste

SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES

-

Page 88-89, (2008/06/13)

Disclosed are compounds of formula (I), wherein R1 and R2 are defined herein, which are useful as inhibitors of the kinase activity of the IκB kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 635731-97-4